KIORA PHARMACEUTICALS, INC. Lease, Cost
KIORA PHARMACEUTICALS, INC. (KPRX) reported Lease, Cost of $67.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LeaseCost · last filed 2026-08-07
- KIORA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2026-06-30 was $67.00K, a 78.67% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2026-03-31 was $55.70K, a 92.07% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2025-09-30 was $23.30K, a 24.60% increase year-over-year.
- KIORA PHARMACEUTICALS, INC. lease, cost for the quarter ending 2025-06-30 was $37.50K, a 103.80% increase year-over-year.
| Period end | Lease, Cost 3 month | Lease, Cost 3 month as first filed | Lease, Cost 6 month | Lease, Cost 6 month as first filed | Lease, Cost 9 month | Lease, Cost 9 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67.00K 10-Q · filed 2026-08-07 | $122.70K 10-Q · filed 2026-08-07 | ||||
| 2026-03-31 | $55.70K 10-Q · filed 2026-05-08 | |||||
| 2025-09-30 | $23.30K 10-Q · filed 2025-11-07 | $60.80K derived: sum of 2 quarters · filed 2026-08-07 | $51.30K 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | $37.50K 10-Q · filed 2026-08-07 | $14.20K 10-Q · filed 2025-08-08 | $66.50K 10-Q · filed 2026-08-07 | $28.00K 10-Q · filed 2025-08-08 | ||
| 2025-03-31 | $29.00K 10-Q · filed 2026-05-08 | $13.85K 10-Q · filed 2025-05-09 | ||||
| 2024-09-30 | $18.70K 10-Q · filed 2025-11-07 | $18.74K 10-Q · filed 2024-11-08 | $37.10K derived: sum of 2 quarters · filed 2025-11-07 | $57.30K 10-Q · filed 2025-11-07 | $57.33K 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $18.40K 10-Q · filed 2025-08-08 | $18.35K 10-Q · filed 2024-08-09 | $38.60K 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | $20.23K 10-Q · filed 2025-05-09 | |||||
| 2023-09-30 | $50.48K 10-Q · filed 2024-11-08 | $91.14K derived: sum of 2 quarters · filed 2024-11-08 | $121.16K 10-Q · filed 2024-11-08 | |||
| 2023-06-30 | $40.65K 10-Q · filed 2024-08-09 | $70.65K 10-Q · filed 2023-08-08 | ||||
| 2023-03-31 | $30.00K 10-Q · filed 2024-05-10 | |||||
| 2022-09-30 | $39.51K 10-Q · filed 2023-11-09 | $65.04K derived: sum of 2 quarters · filed 2023-11-09 | $120.27K 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $25.53K 10-Q · filed 2023-08-08 | $80.53K 10-Q · filed 2023-08-08 | ||||
| 2022-03-31 | $55.00K 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |